Related Experiment Video
Updated: Jun 23, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer
Patrícia Savio de Araujo Souza1, Laura Sichero, Paulo Cesar Maciag
1Division of Cellular Biology, Brazilian National Cancer Institute, R Andre Cavalcanti, 37-5o andar, 22231-090 Rio de Janeiro, Brazil. psas@inca.gov.br
Abstract:
Human papillomavirus (HPV) infection is linked to the development of cervical cancer, and several cofactors contribute to the risk of disease. Research on the intratypic variability of HPVs has defined variants that are associated with persistent infections and are potentially more oncogenic, translating to a higher risk of malignant disease. The genetic variability of the host also plays a role in the risk of cervical cancer, especially genes controlling the immune response, such as HLA class I and II. These highly polymorphic genes are important risk determinants of HPV persistence and disease progression. The interaction between host and viral factors is complex and needs to be further investigated, paving the way to better define the patients at the highest risk of developing malignant diseases linked to HPV infection.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs
Histone Variants at the Centromere
Principles of Pharmacogenetics: Types of Genetic Variants
Cancer Prevention
Some...
